Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for thera...
Saved in:
Main Authors: | Clarissa S. Santoso (Author), Zhaorong Li (Author), Jaice T. Rottenberg (Author), Xing Liu (Author), Vivian X. Shen (Author), Juan I. Fuxman Bass (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
by: Cohen S, et al.
Published: (2019) -
No one is safe! But who's more susceptible? Locus of control moderates pandemic perceptions' effects on job insecurity and psychosocial factors amongst MENA hospitality frontliners: a PLS-SEM approach
by: Ali B. Mahmoud, et al.
Published: (2021) -
Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders
by: Ramasatyaveni Geesala, et al.
Published: (2021) -
Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management
by: Tao Hu
Published: (2022) -
Trick or treat? - when children with childhood food allergies lead parents into unhealthy food choices
by: Ali B. Mahmoud, et al.
Published: (2020)